# data[].attributes.body
The video reviewed literature to distinguish myths from reality and see what we really know about how migration affects the labor markets, budgets, income inequality, and other aspects in both receiving and origin countries. It also looked at the policies that countries can adopt to increase benefits and minimize the costs of migration.

# data[].attributes.attachment_link.title
Migration: The Impact on Countries of Origin and Receiving Countries

# data[].attributes.headline
How Does Immigration Impact the Economy? 

# data[].attributes.subject
How Does Immigration Impact the Economy? 

# data[].attributes.body
https://www.youtube.com/watch?v=f0dVfDiSrFo
When discussing the topic of immigration and development, the best case study one can put forward is of course "the nation of immigrants." Beginning from its founding by immigrants till now the topic of immigration has always been at the forefront of social, political and economic discussions in the US. This brief CNBC explainer discusses the impact of immigration on the host country's economic development taking America as a case study. Some of the key points the presenter raises are:

An extra 1% increase in a country's migrant population adds on a 2% GDP per capita in the long term

Migration is a risk that causes many migrants to be entrepreneurial.

Both high and low skilled migrants contribute to increased productivity

# data[].attributes.attachment_link.title
How does immigration impact the economy? | CNBC Explains

# data[].attributes.headline
HBR: Why Immigrants Are More Likely to Become Entrepreneurs?

# data[].attributes.subject
HBR: Why Immigrants Are More Likely to Become Entrepreneurs?

# data[].attributes.body
Resonating with and adding to the infographic shared by Kena, businesses started by immigrants are a lot! In the US where the immigrant population is 13.7%, the start-ups started by immigrants are 25% and a whopping 55% of the US-based unicorns were founded or co-founded by an immigrant. Furthermore, if you are vaccinated with Pfizer, BioNTech or Moderna - you have an immigrant entrepreneur to be grateful to since all three companies were founded or co-founded by one.
The Harvard Business Review short article sheds more light as to why immigrants are more likely to start a business than the native population. Similarly to the paper in review, the article also calls for policies and regulations the implications of which are aimed at fostering the positive impact of immigrants on entrepreneurship.

# data[].attributes.attachment_link.title
Research: Why Immigrants Are More Likely to Become Entrepreneurs

# data[].attributes.attachment_link.description
If you're lucky enough to have received a Covid-19 vaccination, you probably have an immigrant entrepreneur to thank. Not only are Pfizer, BioNTech, and Moderna pioneers in the field of mRNA-based vaccine research; they were all founded or cofounded by immigrants.* The entrepreneurs who started those companies are prominent examples of a larger trend.

# data[].attributes.body
This paper poses and answers a number of critical questions about the relationship
between migration and entrepreneurship in the process of economic development.
In doing so, we show that the standard policy response to migrants and migrant
entrepreneurs are often based on an inadequate understanding of migrant entrepreneurs.
The questions we pose are the following: (i) Are immigrants really more entrepreneurial
than natives? (ii) Are migrant remittances likely to fund entrepreneurship in their home
countries? (iii) Are return migrants more likely to be entrepreneurial than non-migrants?
And finally, based on the answers, (iv) Does migration matter for development? We
conclude that one must avoid seeing migrants as super-entrepreneurs and that the
(positive) developmental impact of migration is more significant through other channels.
Removal of discriminatory barriers against migrants and against migrant entrepreneurs in
labour, consumer and financial markets will promote development in both sending and
receiving countries, not least through reducing the shares of migrants that are reluctant

# data[].attributes.attachment_link.title
Migration, entrepreneurship and development: critical questions | Semantic Scholar

# data[].attributes.attachment_link.description
AbstractThis paper poses and answers a number of critical questions about the relationship between migration and entrepreneurship in the process of economic development. In doing so, we show that the standard policy response to migrants and migrant entrepreneurs are often based on an inadequate understanding of migrant entrepreneurs.

# data[].attributes.body
Hi SEPTies!

I found this podcast very interesting. In each episode, they explain more in detail about the process, funding, and barriers to being an entrepreneur in European Union. This initiative is to facilitate better integration to all the migrants coming to Europe, specifically refugees. Therefore, they created this business program founded in the Netherlands.

This entrepreneurial program to migrants is a good way of learning how to be autonomous in a foreign country even if they do not start their own business. They are going to develop an entrepreneurial mindset that will help them in different aspects of their lives.

# data[].attributes.attachment_link.readable_text
In this first episode you will learn how to take the first steps as a migrant entrepreneur and how intermediary organisations can support you. How do you start with your business? And how can support organizations help migrants with the first steps to become an entrepreneur?-

Podcast host Annette van Soest talks with: -

# data[].attributes.attachment_link.title
Migrant In Business Pod #1 - business as usual?

# data[].attributes.attachment_link.description
Listen to this episode from The Migrant In Business Pod on Spotify. In this first episode you will learn how to take the first steps as a migrant entrepreneur and how intermediary organisations can support you. How do you start with your business?

# data[].attributes.headline
What Immigrants need to know for a Successful  Business in Germany

# data[].attributes.subject
What Immigrants need to know for a Successful  Business in Germany

# data[].attributes.body
https://www.iamexpat.de/expat-info/german-expat-news/what-you-need-know-about-business-immigration-germany

# data[].attributes.attachment_link.title
What you need to know about business immigration to Germany

# data[].attributes.attachment_link.description
Schlun & Elseven look at business immigration to Germany, including the requirements for obtaining a residence permit for the purpose of self-employment.

# data[].attributes.body
In this podcast, professor Melissa Siegel talks about the aspirations that drive people's decisions to live elsewhere. Through her research, Melissa debunks the idea that people migrate only to escape poverty and conflict, and that development in sending countries reduces emigration https://www.imiscoe.org/news-and-blog/podcast/1101-melissa-siegel-on-common-misconceptions-about-migration-and-development

# data[].attributes.attachment_link.title
Misconceptions about migration and development - IMISCOE

# data[].attributes.attachment_link.description
IMISCOE is the largest European network of scholars in the area of migration and integration. The focus is on comparative research and joint research projects.

# data[].attributes.body
Language and integrating to the culture barriers are the biggest challenge to the migrant. Rafael shares the reality of million of migrants around the world in this video

# data[].attributes.attachment_link.title
What it takes to be a migrant entrepreneur | Rafael dos Santos | TEDxRoyalTunbridgeWells

# data[].attributes.attachment_caption
Migrant start-ups support entrepreneurial activity in Germany | KfW

# data[].attributes.body
Hi Septies, I just came cross with this blog pages, and found it’s useful to read for someone wants to know more about the supports for migrants starting business in Germany.

# data[].attributes.attachment_link.readable_text
Migrants accounted for one in four start-ups in 2019

The labour market, a willingness to take risks and role models are the three main drivers

Coronavirus crisis is both risk and opportunity for start-ups

Start-ups by migrants are again playing a more important role for entrepreneurship in Germany. In 2019, their share in newly founded businesses grew by a notable five percentage points to 26% on the previous year. This is the finding of a special analysis conducted by KfW Research as part of the KfW Entrepreneurship Monitor. Fewer opportunities in the labour market, a higher willingness to take risks and the stronger effect of role models give migrants more entrepreneurial motivation than the general population. Early results show that migrant start-ups are more innovative and more growth-oriented. Migrants are understood to be persons who do not have or were not born with German citizenship.

Among migrants the entrepreneur rate, the number of business founders per 10,000 employable persons, is 137. The rate converged on the average until 2017 but has since increased again. Recently the entrepreneur rate for the overall population was just 117 by comparison. Accordingly, 160,000 of the 605,000 start-ups of the year 2019 were created by migrants.

"Start-ups are important for an economy's innovative capacity and, thus, for its sustainability. That means Germany has for many years benefited from migrants' increased willingness to become entrepreneurs. That proved to be true again in 2019. Even if lower employment opportunities play a role more often in the decision to start a business, migrants' innovative spirit and growth orientation offer great possibilities", said Dr Fritzi Köhler-Geib, Chief Economist of KfW. "This year is a particular challenge for entrepreneurs because of the coronavirus crisis. Many start-up plans were put off temporarily. But the crisis can also act as a catalyst for innovation. Entrepreneurs who meet the new needs with innovative business ideas can be the great winners of tomorrow."

The current analysis by KfW Research on migrant start-ups can be retrieved from https://www.kfw.de/KfW-Konzern/Service/Download-Center/Konzernthesearch/Volkswirtschaft-Kompakt/men/Re

# data[].attributes.attachment_link.title
Migrant start-ups support entrepreneurial activity in Germany | KfW

# data[].attributes.attachment_link.description
Migrants accounted for one in four start-ups in 2019 The labour market, a willingness to take risks and role models are the three main drivers Coronavirus crisis is both risk and opportunity for start-ups Start-ups by migrants are again playing a more important role for entrepreneurship in Germany.

# data[].attributes.body
This Economist video explores the remarkable benefits that a shift in migration policy would have in both the migrant’s origin and destination country. It is estimated that the world's GDP would be roughly double in somewhere between 50 and 150 percent bigger every year if people were allowed to work where they wanted. In addition to income growth (mainly though remittances), the video also argues for the creation of trade ties, technology transfer and the investment links that migration allows. Worth a view.

# data[].attributes.attachment_link.title
How migration could make the world richer | The Economist

# data[].attributes.body
This news is a short history of BioNTech which is one of the most successful migrant entrepreneurship projects.

# data[].attributes.attachment_link.readable_text
LONDON - Before 2020, Germany's BioNTech was a relatively little-known biotechnology company. That all changed when Covid-19 arrived.

On Monday, U.S. drug maker Pfizer announced an early analysis of its coronavirus vaccine - developed in partnership with BioNTech - was more than 90% effective in preventing Covid-19 among those without evidence of prior infection.

The news was hailed as a significant milestone in the race to deliver a vaccine that can help bring an end to the coronavirus pandemic. White House coronavirus advisor Dr. Anthony Fauci had previously said a vaccine that is 50% or 60% effective would be acceptable.

There are still huge challenges ahead for the development of a safe and effective vaccine, but as hopes rise worldwide, CNBC takes a look at BioNTech's history.

Power couple

BioNTech (pronounced bye-on-tech) was founded in the city of Mainz in 2008 by husband and wife duo Ugur Sahin and Ozlem Tureci.

Both Sahin and Tureci are the children of Turkish immigrants. Sahin's father worked at a Ford factory in Cologne while Tureci's was a doctor. Sahin heads up BioNTech as its CEO while Tureci is the firm's chief medical officer.

Their entrepreneurial journey began in 2001 when they set up Ganymed Pharmaceuticals, another German biotech firm focused on developing immunotherapeutic cancer drugs. That company was acquired by Japan's Astellas for up to 1.3 billion euros ($1.5 billion) in late 2016.

At the time, Sahin and Tureci were already working on BioNTech, which would look to develop a broader range of cancer immunotherapies. Their research centered on messenger RNA (mRNA) molecules, which transport instructions to the part of the cell that creates proteins.

Nasdaq-listed BioNTech has seen its shares surge over 230% since the start of the year, lifting its market value close to $27 billion. Another biotech firm in the mRNA space, Moderna, has seen its stock skyrocket nearly 290% in that same period. According to the weekly Welt am Sonntag newspaper, Sahinby and Tureci now rank among the 100 richest Germans.

Pfizer partnership

In January, Sahin instructed his company to devote its resources to tackling the novel coronavirus that had emerged in China.

BioNTech, which had already been working with Pfizer on a flu vaccine, then agreed in March to a tie-up with the American pharma giant that would see them co-develop and distribute a potential vaccine for Covid-19.

"We are a next-generation immunotherapy company," Sahin told CNBC's "Power Lunch" on Tuesday. "The technology behind this vaccine, the messenger RNA technology, and the vaccine candidates have been developed in Germany."

Sahin went on to explain that BioNTech "took care of the manufacturing of the batches for the clinical trial." BioNTech also specializes in T-cell, a key part of the immune system, and "investigated the T-cell immune responses for this vaccine," according to its chief.

Pfizer took care of clinical trials in the U.S. while BioNTech conducted its own trials in Germany, Sahin said, adding that Pfizer was responsible for executing the global late-stage trial that led to the 90% efficacy revelation on Monday.

Dr. Albert Bourla, the CEO of Pfizer, called that development "a great day for science and humanity." Sahin agrees: "It was a wonderful moment because we didn't expect this high efficacy rate."

Those results are subject to an independent review, but provide some promise amid the mammoth global effort to develop an effective vaccine. Still, distribution is likely to prove a challenge: Pfizer's vaccine requires a storage temperature of minus 94 degrees Fahrenheit and cannot be removed more than four times.

# data[].attributes.attachment_link.title
What you need to know about BioNTech - the European company behind Pfizer's Covid-19 vaccine

# data[].attributes.attachment_link.description
LONDON - Before 2020, Germany's BioNTech was a relatively little-known biotechnology company. That all changed when Covid-19 arrived. On Monday, U.S. drug maker Pfizer announced an early analysis of its coronavirus vaccine - developed in partnership with BioNTech - was more than 90% effective in preventing Covid-19 among those without evidence of prior infection.

# data[].attributes.body
The video shows how powerful immigrant entrepreneurship is based on the example of USA (Central America).

# data[].attributes.attachment_link.title
Immigrant Entrepreneurship: America's Secret Weapon | Francisco Aguilar | TEDxBoston